Michael Hund

Michael Hund, MBA, is an award-winning Founder and CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing and medtech entrepreneurship. His leadership has been highlighted by MIT, Yale, Harvard, Stanford, Cambridge, the Wall Street Journal, CNN, CNBC, Forbes, and the Milken Institute. He is the CEO of EB Research Partnership, a groundbreaking medical research organization dedicated to curing Epidermolysis Bullosa through its proven Venture Philanthropy model, and Co-Founder and CEO of Rare Ventures, a first-of-its-kind rare disease accelerator using that model to advance treatments across the broader rare disease community. Under his leadership EBRP has raised more than $100 million to transform the landscape from 2 to over 50 clinical trials and accelerated 3 FDA approved treatments in the last three years.

He is Executive Producer of the award-winning Netflix documentary Matter of Time and Executive Producer of Venture into Cures, a movement combining stories of the patient and medical communities with musicians and actors. Michael received his MBA from Yale University, CORe credential from Harvard Business School, and a degree in Philosophy from the University of Kansas.

He is the recipient of the MIT Solve Innovation Award, iHeart Media’s CEOs You Should Know, the Milken Institute’s Changemaker and LeadersLink, Fast Company's Impact Council, and Social Innovations Journal Leadership Award.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.